MedPath

Prevalence of vulnerable plaque in type 2 Diabetes Mellitus and its predictive value for future ischemic strokes

Withdrawn
Conditions
atherosclerosis
diabetes
10082206
10003216
Registration Number
NL-OMON41735
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Withdrawn
Sex
Not specified
Target Recruitment
1680
Inclusion Criteria

* Subjects enrolled in de maastricht studie
* Subjects who have atherosclerotic plaques * 2mm, demonstrated in the carotid artery during vascular ultrasound in de maastricht studie.

Exclusion Criteria

* Pregnancy.
* Standard contra-indications for MRI (ferromagnetic implants like pacemakers or other electronic implants, metallic eye fragments, vascular clips, claustrophobia, etc).

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Presence of a vulnerable carotid plaque with intraplaque haemorrhage on MRI (on<br /><br>the left and/or right-hand side) in asymptomatic individuals with type 2<br /><br>diabetes, impaired and normal glucose tolerance and a 2 mm plaque as identified<br /><br>by an ultrasound examination.<br /><br>Number of new ischemic stroke events after 10 years of follow-up. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Presence of brain infarct(s) on brain MRI.<br /><br>Number of cardiovascular events after 10 years of follow-up<br /><br>Subject characteristics (age, gender, cardiovascular risk factors, previous<br /><br>cardiovascular symptoms)<br /><br>Glucose tolerance tests </p><br>
© Copyright 2025. All Rights Reserved by MedPath